PROCESS FOR PREPARING SUBSTITUTED 0-PROPYLOXIMES

    公开(公告)号:KR810000559B1

    公开(公告)日:1981-06-01

    申请号:KR770003022

    申请日:1977-12-24

    Applicant: HOECHST AG

    Abstract: Substituted O-propyloximes(I; R1 = H, carboxyl, C1-6 alkyl or alkenyl; R2 = H, C1-3 alkyl, R3 = H, hydroxy, acyloxy; R4 = H, C1-3 alkyl, phenyl group; R5 = H, halogen, C1-2 alkoxy, hydroxy group; X = N, methyl; M = H, alkaline metal, alkali earth metal cation; n = 1 or valence of cation; Y = halogen, active sulfonic ester; Z = halogen, active sulfonic ester), useful for treatment of catatonia, were prepd. by reaction of O-alkylated oxime(II) and compd.(III). The carbonyl compd.(IV) or its active derivs. were reacted with hydroxylamine derivs.(V) to give intermediate(II).

    NOVEL O-PROPYLOXIMES
    3.
    发明专利

    公开(公告)号:ZA777586B

    公开(公告)日:1978-11-29

    申请号:ZA777586

    申请日:1977-12-21

    Applicant: HOECHST AG

    Abstract: Compounds of general formula (I) wherein R1 represents a radical selected from the group consisting of (a) hydrogen, carboxyl; (b) alkyl, alkenyl each having up to 6 carbon atoms and their phenyl substituted derivatives; (c) at most binuclear unsubstituted aryl, at most binuclear aryl substituted by from 1 to 3 substituents selected from the group consisting of alkyl and alkoxy each having up to 6 carbon atoms, benzloxy, haloalkyl having up to 2 carbon atoms, halogen, cyano and nitro; amino, carboxyl and hydroxy; amino, carboxyl and hydroxy each being substituted by alkyl having at most 2 carbon atoms, methylenedioxy groups and O- -hydroximinom ethyl groups; (d) at most bicyclic unsubstituted heteroaromatic group having 1 to 4 heteroatoms selected from the group consisting of nitrogen, one sulphur and one oxygen in the ring system and such a heteroaromatic group being substituted by at most 3 substituents selected from the group consisting of alkyl, alkoxy each having up to 2 carbon atoms, phenylalkyl having up to 3 carbon atoms in the alkyl moiety, halogen, methylamino and dimethylamino; R2 represents a member selected from the group consisting of hydrogen, alkyl having up to 3 carbon atoms, cycloalkyl having up to 6 carbon atoms and phenyl; and R1 and R2, together with the carbon atom to which they are attached, form a radical selected from the group consisting of fluorene-9-ylidene and a cycloaliphatic group having up to 10 carbon atoms and such a cycloaliphatic group containing a hydrocarbon bridging group; R3 represents a member selected from the group consisting of hydrogen hydroxy and acyloxy; R4 represents a member selected from the group consisting of hydrogen alkyl having up to 3 carbon atoms and phenyl; R5 represents a member selected from the group consisting of halogen, alkoxy having up to 2 carbon atoms and hydroxy; and X represents a member selected from the group consisting of nitrogen and methine and physiologically acceptable acid addition salts thereof; a pharmaceutical composition containing said compounds.

    O-ALKYLATED OXIMES
    4.
    发明专利

    公开(公告)号:ZA777584B

    公开(公告)日:1978-11-29

    申请号:ZA777584

    申请日:1977-12-21

    Applicant: HOECHST AG

    Abstract: Compounds of general formula (I) wherein R1 represents a member selected from the group consisting of (a) an unsubstituted at most binuclear aryl group having from 6 to 10 carbon atoms, such groups substituted by from 1 to 3 equal or different radicals selected from the group consisting of alkyl, halogenoalkyl, alkoxy, dialkylamino each having up to 4 carbon atoms in the alkyl moiety, halogen phenyl, carboxyl, cyano, nitro and hydroxy groups, (b) a 5- to 6-membered heteroaromatic ring wherein the heteroatom is selected from nitrogen, oxygen and sulfur atoms and such rings anellated to a benzene nucleus; R2 represents a member selected from the group consisting of hydrogen, alkyl having up to 3 carbon atoms, phenyl, cycloalkyl having up to 6 carbon atoms in the ring and cycloalkyl bearing a hydrocarbon bridging radical having up to 2 carbon atoms; R3 represents hydrogen, hydroxy or acyloxy; R4 and R5 are the same or different and each represents a member selected from the group consisting of halogen, alkyl, and halogenoalkyl each having up to 3 carbon atoms, and nitro; and X represents nitrogen or methine and physiologically acceptable acid addition salts thereof and a pharmaceutical composition containing said compounds.

Patent Agency Ranking